This website is intended for use by US healthcare professionals only.
Be in your
element
Focus on what you do best with Tralement® (trace elements injection 4*, USP) and Multrys™ (trace elements injection 4*, USP) formulations for parenteral nutrition (PN).
Tralement® and Multrys™ are the first and only
FDA-approved multi-trace element (MTE) formulations.1,2
Trace elements (TEs) are essential. Per ASPEN clinical recommendations, patients should receive a daily
dose of TEs as part of their PN order.3
Tralement® and Multrys™ are the first and only FDA-approved multi-trace element (MTE) formulations.1,2
Trace elements (TEs) are essential. Per ASPEN clinical recommendations, patients should receive a daily dose of TEs as part of their PN order.3
Our Commitment to Parenteral Nutrition (PN)
American Regent is committed to supporting the needs of clinicians and their patients. View highlights from our 30+ years of partnering with the PN community.
Today
For more than 50 years, American Regent
has set a higher standard of dedication,
bringing speed, flexibility, reliability, and
quality to the forefront of the hospital
injectable manufacturer market.
2021
Multrys™ (trace elements injection 4*, USP)
is the first FDA-approved multi-trace element
injection for parenteral nutrition for neonatal
and pediatric patients weighing less than 10 kg.2
*Each mL of Tralement® contains zinc 3 mg,
copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.
Each mL of Multrys™ contains zinc 1,000 mcg,
copper 60 mcg, manganese 3 mcg, and selenium 6 mcg.
2020
Tralement® (trace elements injection 4*, USP),
the first FDA-approved multi-trace element
injection for parenteral nutrition is introduced
for patients weighing at least 10 kg.1
*Each mL of Tralement® contains zinc 3 mg,
copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.
Each mL of Multrys™ contains zinc 1,000 mcg,
copper 60 mcg, manganese 3 mcg, and selenium 6 mcg.
2020
American Regent commits to completing
a randomized controlled trial that evaluates
manganese in patients receiving
parenteral nutrition (PN).
2020
Nine-day stability studies established
that Tralement®, Zinc Sulfate Injection, USP;
and Selenious Acid Injection, USP can be safely
stored for up to 9 days when added to the
PN admixture and refrigerated—
allowing for advanced preparation.4,6,7
2020
FDA-approved Zinc Sulfate Injection,
USP, is introduced for use in adult
and pediatric patients.8
2019
Launch of the first and only FDA-approved
Selenious Acid Injection, USP.9
American Regent, Inc., merges with Luitpold
Pharmaceuticals, Inc. The company name is
changed to American Regent.
2017
American Regent celebrates its 50th
anniversary of service in supporting
the clinical community.
2015
The Trace Elements Medical Advisory Board
sponsored by American Regent begins
development of Tralement® multi-trace element
formulation injection for PN.
2009
The Academy of Nutrition and Dietetics and
ASPEN collaborate to set new standards to
help diagnose malnutrition in adults, and set
standards with measurable criteria for healthcare
professionals to use.10
1994
American Regent introduces:
Multitrace®-4 (Trace Elements Injection 4, USP)
10 mL multi-dose vial (MDV)
Multitrace®-5 (Trace Elements Injection 5, USP)
10 mL MDV
1993
American Regent introduces:
Multitrace®-4 Concentrate (Trace Elements
Injection 4, USP) 1 mL single-dose vial (SDV)
and 10 mL MDV
Multitrace®-5 Concentrate (Trace Elements
Injection 5, USP) 1 mL SDV and 10 mL MDV
Multitrace®-4 Pediatric (Trace Elements Injection 4, USP) 3 mL SDV
1993
American Regent introduces:
Multitrace®-4 Concentrate (Trace Elements
Injection 4, USP) 1 mL single-dose vial (SDV)
and 10 mL MDV
Multitrace®-5 Concentrate (Trace Elements
Injection 5, USP) 1 mL SDV and 10 mL MDV
Multitrace®-4 Pediatric (Trace Elements Injection 4, USP) 3 mL SDV
1984
American Regent introduces Selenium
Injection 40 mcg/mL to its product line—
our first trace element (TE) product, and
the beginning of a long line of TE injectables
to support the PN community.
1967
Our company is launched by a group of
dedicated professionals under the name
American Quinine, providing quality parenteral
nutrition products to medical
communities within the US and Canada.
Today
For more than 50 years, American Regent
has set a higher standard of dedication,
bringing speed, flexibility, reliability, and
quality to the forefront of the hospital
injectable manufacturer market.
2021
Multrys™ (trace elements injection 4*, USP)
is the first FDA-approved multi-trace element
injection for parenteral nutrition for neonatal
and pediatric patients weighing less than 10 kg.2
*Each mL of Tralement® contains zinc 3 mg,
copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.
Each mL of Multrys™ contains zinc 1,000 mcg,
copper 60 mcg, manganese 3 mcg, and selenium 6 mcg.
2020
Tralement® (trace elements injection 4*, USP),
the first FDA-approved multi-trace element
injection for parenteral nutrition is introduced
for patients weighing at least 10 kg.1
*Each mL of Tralement® contains zinc 3 mg,
copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.
Each mL of Multrys™ contains zinc 1,000 mcg,
copper 60 mcg, manganese 3 mcg, and selenium 6 mcg.
2020
American Regent commits to completing
a randomized controlled trial that evaluates
manganese in patients receiving
parenteral nutrition (PN).
2020
Nine-day stability studies established
that Tralement®, Zinc Sulfate Injection, USP;
and Selenious Acid Injection, USP can be safely
stored for up to 9 days when added to the
PN admixture and refrigerated—
allowing for advanced preparation.4,6,7
2020
FDA-approved Zinc Sulfate Injection,
USP, is introduced for use in adult
and pediatric patients.8
2019
Launch of the first and only FDA-approved
Selenious Acid Injection, USP.9
American Regent, Inc., merges with Luitpold
Pharmaceuticals, Inc. The company name is
changed to American Regent.
2017
American Regent celebrates its 50th
anniversary of service in supporting
the clinical community.
2015
The Trace Elements Medical Advisory Board
sponsored by American Regent begins
development of Tralement® multi-trace element
formulation injection for PN.
2009
The Academy of Nutrition and Dietetics and
ASPEN collaborate to set new standards to
help diagnose malnutrition in adults, and set
standards with measurable criteria for healthcare
professionals to use.10
1994
American Regent introduces:
Multitrace®-4 (Trace Elements Injection 4, USP)
10 mL multi-dose vial (MDV)
Multitrace®-5 (Trace Elements Injection 5, USP)
10 mL MDV
1993
American Regent introduces:
Multitrace®-4 Concentrate (Trace Elements
Injection 4, USP) 1 mL single-dose vial (SDV)
and 10 mL MDV
Multitrace®-5 Concentrate (Trace Elements
Injection 5, USP) 1 mL SDV and 10 mL MDV
Multitrace®-4 Pediatric (Trace Elements Injection 4, USP) 3 mL SDV
1993
American Regent introduces:
Multitrace®-4 Concentrate (Trace Elements
Injection 4, USP) 1 mL single-dose vial (SDV)
and 10 mL MDV
Multitrace®-5 Concentrate (Trace Elements
Injection 5, USP) 1 mL SDV and 10 mL MDV
Multitrace®-4 Pediatric (Trace Elements Injection 4, USP) 3 mL SDV
1984
American Regent introduces Selenium
Injection 40 mcg/mL to its product line—
our first trace element (TE) product, and
the beginning of a long line of TE injectables
to support the PN community.
1967
Our company is launched by a group of
dedicated professionals under the name
American Quinine, providing quality parenteral
nutrition products to medical
communities within the US and Canada.
Today
For more than 50 years, American Regent
has set a higher standard of dedication,
bringing speed, flexibility, reliability, and
quality to the forefront of the hospital
injectable manufacturer market.
2021
Multrys™ (trace elements injection 4*, USP)
is the first FDA-approved multi-trace element
injection for parenteral nutrition for neonatal
and pediatric patients weighing less than 10 kg.2
*Each mL of Tralement® contains zinc 3 mg,
copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.
Each mL of Multrys™ contains zinc 1,000 mcg,
copper 60 mcg, manganese 3 mcg, and selenium 6 mcg.
2020
Tralement® (trace elements injection 4*, USP),
the first FDA-approved multi-trace element
injection for parenteral nutrition is introduced
for patients weighing at least 10 kg.1
*Each mL of Tralement® contains zinc 3 mg,
copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.
Each mL of Multrys™ contains zinc 1,000 mcg,
copper 60 mcg, manganese 3 mcg, and selenium 6 mcg.
2020
American Regent commits to completing
a randomized controlled trial that evaluates
manganese in patients receiving
parenteral nutrition (PN).
2020
Nine-day stability studies established
that Tralement®, Zinc Sulfate Injection, USP;
and Selenious Acid Injection, USP can be safely
stored for up to 9 days when added to the
PN admixture and refrigerated—
allowing for advanced preparation.4,6,7
2020
FDA-approved Zinc Sulfate Injection,
USP, is introduced for use in adult
and pediatric patients.8
2019
Launch of the first and only FDA-approved
Selenious Acid Injection, USP.9
American Regent, Inc., merges with Luitpold
Pharmaceuticals, Inc. The company name is
changed to American Regent.
2017
American Regent celebrates its 50th
anniversary of service in supporting
the clinical community.
2015
The Trace Elements Medical Advisory Board
sponsored by American Regent begins
development of Tralement® multi-trace element
formulation injection for PN.
2009
The Academy of Nutrition and Dietetics and
ASPEN collaborate to set new standards to
help diagnose malnutrition in adults, and set
standards with measurable criteria for healthcare
professionals to use.10
1994
American Regent introduces:
Multitrace®-4 (Trace Elements Injection 4, USP)
10 mL multi-dose vial (MDV)
Multitrace®-5 (Trace Elements Injection 5, USP)
10 mL MDV
1993
American Regent introduces:
Multitrace®-4 Concentrate (Trace Elements
Injection 4, USP) 1 mL single-dose vial (SDV)
and 10 mL MDV
Multitrace®-5 Concentrate (Trace Elements
Injection 5, USP) 1 mL SDV and 10 mL MDV
Multitrace®-4 Pediatric (Trace Elements Injection 4, USP) 3 mL SDV
1993
American Regent introduces:
Multitrace®-4 Concentrate (Trace Elements
Injection 4, USP) 1 mL single-dose vial (SDV)
and 10 mL MDV
Multitrace®-5 Concentrate (Trace Elements
Injection 5, USP) 1 mL SDV and 10 mL MDV
Multitrace®-4 Pediatric (Trace Elements Injection 4, USP) 3 mL SDV
1984
American Regent introduces Selenium
Injection 40 mcg/mL to its product line—
our first trace element (TE) product, and
the beginning of a long line of TE injectables
to support the PN community.
1967
Our company is launched by a group of
dedicated professionals under the name
American Quinine, providing quality parenteral
nutrition products to medical
communities within the US and Canada.
Today
For more than 50 years, American Regent
has set a higher standard of dedication,
bringing speed, flexibility, reliability, and
quality to the forefront of the hospital
injectable manufacturer market.
2021
Multrys™ (trace elements injection 4*, USP)
is the first FDA-approved multi-trace element
injection for parenteral nutrition for neonatal
and pediatric patients weighing less than 10 kg.2
*Each mL of Tralement® contains zinc 3 mg,
copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.
Each mL of Multrys™ contains zinc 1,000 mcg,
copper 60 mcg, manganese 3 mcg, and selenium 6 mcg.
2020
Tralement® (trace elements injection 4*, USP),
the first FDA-approved multi-trace element
injection for parenteral nutrition is introduced
for patients weighing at least 10 kg.1
*Each mL of Tralement® contains zinc 3 mg,
copper 0.3 mg, manganese 55 mcg, and selenium 60 mcg.
Each mL of Multrys™ contains zinc 1,000 mcg,
copper 60 mcg, manganese 3 mcg, and selenium 6 mcg.
2020
American Regent commits to completing
a randomized controlled trial that evaluates
manganese in patients receiving
parenteral nutrition (PN).
2020
Nine-day stability studies established
that Tralement®, Zinc Sulfate Injection, USP;
and Selenious Acid Injection, USP can be safely
stored for up to 9 days when added to the
PN admixture and refrigerated—
allowing for advanced preparation.4,6,7
2020
FDA-approved Zinc Sulfate Injection,
USP, is introduced f